Kisqali 400MG tab 42S
Ended Awarded
- Contract number
- SPE2DR26FBATR
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $29,459
Award facts
- Contract value 100% obligated
- $29,458.83 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $29,458.83 delivery order to Amerisourcebergen Drug Corp on June 1, 2026, for KISQALI 400MG TAB 42S, with a ceiling value of $29,458.83 and an ultimate completion date of June 23, 2026.
Place of performance is Conshohocken, PA. The order is firm fixed price and carries no set-aside.
Quick answers
Who was awarded contract SPE2DR26FBATR?
SPE2DR26FBATR was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 1, 2026.
How much is contract SPE2DR26FBATR worth?
The government has obligated $29,459 on SPE2DR26FBATR.
Is contract SPE2DR26FBATR an order under another contract?
Yes. SPE2DR26FBATR is a delivery order under SPE2DR25D6028, an indefinite delivery contract.
Was contract SPE2DR26FBATR competed?
The extent of competition for SPE2DR26FBATR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award